AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company that was founded in 2019 based on research in antibiotic products at the University of Oslo (UoO), Norway.
The company vision is to provide novel antibiotic resistance breakers to meet the imminent threat to modern medicine of antimicrobial resistance (AMR).
AdjuTec's core technology is synthesis of β-lactamase inhibitors (BLIs) that inactivates bacteria resistance enzymes. By taking down bacteria defense we are able to preserve susceptibility of broad-spectrum antibiotics.
Supported by national and EU-grants as well as private funding, AdjuTec will start clinical development of its lead product APC148 in September 2024.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Universitetsgata 2, Oslo,0164,norway
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://adjutecpharma.com/
- Keywords
- Antimicrobial resistance.
- HQ
- Oslo
Adjutec Pharma As Questions
Adjutec Pharma As's website is https://adjutecpharma.com/
Adjutec Pharma As's LinkedIn profile is https://no.linkedin.com/company/adjutec-pharma-as
Adjutec Pharma As has
9 employees.
View email and phone details for 9
employees at Adjutec Pharma As.
Adjutec Pharma As's industry is
Pharmaceutical Manufacturing
Adjutec Pharma As's top competitors are
Agilera Pharma As,
Ås Produksjonslab,
Thelper,
Curida Diatec,
Vistin Pharma As,
Clexbio,
Vilje Bionics,
Hemispherian As,
Curida,
Node Pharma.
Adjutec Pharma As's categories are Pharmaceutical Manufacturing
Adjutec Pharma As's founding year is 2019
